CYTOPLAST MICRODERM Trademark
Trademark Overview
On Monday, August 21, 2023, a trademark application was filed for CYTOPLAST MICRODERM with the United States Patent and Trademark Office. The USPTO has given the CYTOPLAST MICRODERM trademark a serial number of 98142618. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 23, 2024. This trademark is owned by Osteogenics Biomedical, Inc.. The CYTOPLAST MICRODERM trademark is filed in the Pharmaceutical Products category with the following description:
processed human donor skin to facilitate regeneration of soft tissue; wound dressings; pharmaceutical preparations for oral and maxillofacial tissue regeneration and reconstruction; resorbable membranes in the nature of dental surgical implants comprised of biological tissues for oral and maxillofacial tissue regeneration; resorbable membranes in the nature of dental surgical implants comprised of natural and/or processed human tissue for use in guided tissue procedures; human allograft tissue
General Information
| Serial Number | 98142618 |
| Word Mark | CYTOPLAST MICRODERM |
| Filing Date | Monday, August 21, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, July 23, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 28, 2024 |
Trademark Statements
| Description of Mark | "MICRODERM" |
| Goods and Services | processed human donor skin to facilitate regeneration of soft tissue; wound dressings; pharmaceutical preparations for oral and maxillofacial tissue regeneration and reconstruction; resorbable membranes in the nature of dental surgical implants comprised of biological tissues for oral and maxillofacial tissue regeneration; resorbable membranes in the nature of dental surgical implants comprised of natural and/or processed human tissue for use in guided tissue procedures; human allograft tissue |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 20, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Osteogenics Biomedical, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Lubbock, TX 79424 |
| Party Name | Osteogenics Biomedical, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lubbock, TX 79424 |
Trademark Events
| Event Date | Event Description |
| Friday, August 25, 2023 | NEW APPLICATION ENTERED |
| Wednesday, September 20, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 19, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, April 23, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, April 23, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 23, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 23, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, April 23, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 8, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 28, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 28, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, June 6, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, June 6, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, June 6, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, July 23, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, December 16, 2024 | TEAS STATEMENT OF USE RECEIVED |
